Ensuring medical progress with high-quality health data - Interpharma

Leader in research and development

Ensuring medical progress with high-quality health data

Due to the increasing importance of health data, especially real world data, it is crucial that Switzerland invests in building a health data ecosystem.

Overview Artificial intelligence Data transparency Real world data Use of health data

Interpharma members currently invest almost CHF 9 billion annually in research and development in Switzerland (2021; source: member survey). However, Switzerland is losing much of its attractiveness in the competition between locations when it comes to innovation with digital elements (source: BAK Economics). This is because there is hardly a country like Switzerland where digital health data can be used so little to offer patients effective personalised medicine, accelerate medical progress and make the healthcare system sustainable.

In order for Switzerland to catch up in the digital transformation of the healthcare system, it must invest in building a functioning healthcare data ecosystem. This requires the cooperation of the industry, authorities, the academy and other relevant partners. On the one hand, these must work on a comprehensive and coherent strategy with a binding timetable for targeted measures. This includes, among other things, that Switzerland enacts a health data law to complement robust data protection. This should transparently regulate how health data is to be used in Switzerland – and who orchestrates this use. On the other hand, the players in the health sector must invest in lighthouse projects that make tangible the immense benefit that health data ecosystems have for society.

Further information

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2023

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more


Contact us

read more


Latest information and media contacts for media representatives

read more